Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

PCOS is linked to low-grade chronic inflammation.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

TLR3 activation helps improve skin and hair follicle healing in mice.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

CYB5R1 and IL1A genes may be linked to different types of acne scars.

Hairless mice are more vulnerable to Listeria infection, but gut microbiota can help reduce damage.

The study was retracted.

Lgr5 and the vitamin D receptor are key in controlling skin inflammation and tumor risk in mice.

IL-17 and certain immune cells are linked to more severe alopecia areata.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

Blocking IL-17 might help treat the hair loss condition Lichen planopilaris.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

Laminin-511 is essential for proper melanocyte movement and development in mice.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Mcl-1 can activate Wnt signaling in skin cells, promoting growth and possibly cancer.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

MC-1R in skin cells may influence inflammation and collagen production.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.